Pulmonology · Medical Literature

Neural mechanisms of mindfulness-based stress reduction in asthma.

Abstract

Mindfulness-based stress reduction (MBSR) can improve symptoms of chronic inflammation; in asthma, improving asthma control and reducing airway inflammation. Understanding the neural mechanisms underlying these salubrious outcomes could help identify neuroimmune phenotypes and personalize interventions. Adults with asthma were randomized to 8 weeks of MBSR (n = 38) or a wait-list group (n = 34). Clinically relevant asthma-related and psychological outcomes were measured, and task-based fMRI data were acquired during exposure to emotional cues at baseline, post-intervention, and 6mo follow-up. Whole-brain group x time interactions and voxelwise regressions were used to evaluate changes in neural responses to emotion cues from baseline and their relationship to psychological and biological outcomes. Post-intervention, MBSR participants showed decreased lateral prefrontal/orbitofrontal cortex responses to aversive cues relative to controls, which was associated with increased mindfulness. Across participants, decreased salience network reactivity at post-intervention was associated with reduced psychological distress and airway inflammation. At 6 months, some relationships persisted while others did not. Results suggest that mindfulness training reduced effortful regulation of cognitive and affective responses to emotional cues, instead promoting more efficient processing strategies and reduced affective reactivity. Our findings clarify neural mechanisms underlying MBSR's clinical benefits for asthma, underscoring mind-brain-immune relationships as a critical target for asthma treatment.

Clinical relevance

In adults with asthma, does 8 weeks of Mindfulness-Based Stress Reduction (MBSR) produce identifiable neural changes—measured by task-based fMRI—that mediate improvements in psychological outcomes and airway inflammation compared to a wait-list control? __SNAPSHOT__ {"studyDesign":"Randomized controlled trial with task-based fMRI neuroimaging; three assessment time points (baseline, post-intervention, 6-month follow-up)","setting":"University of Wisconsin–Madison (Center for Healthy Minds and Department of Medicine); single academic center, United States","sampleSize":"n = 72 randomized (MBSR: n = 38, wait-list control: n = 34); n = 67 completed post-intervention visit (T2)","population":"Meditation-naïve adults with physician-confirmed asthma; excluded if prior MBSR course completed, meditation retreat history, or mind-body practice within the past year","intervention":"8-week MBSR program: eight weekly 2.5-hour group sessions, one 6-hour intensive retreat, and daily at-home practice; delivered by two certified, experienced MBSR instructors","comparator":"Wait-list control group (offered MBSR at no cost after study completion)","primaryOutcome":"Not formally designated as a single primary endpoint in the abstract; key outcomes included whole-brain BOLD responses to emotional cues (Asthma Stroop task), psychological distress, self-reported mindfulness (FFMQ), and biomarkers of airway inflammation (FeNO reported in related work); voxelwise group × time interactions and regressions used as main fMRI analyses","followUp":"6 months post-randomization (assessments at baseline, immediately post-intervention, and 6-month follow-up)","fundingSource":"Not reported in the provided abstract; manuscript is an early-access, unedited version pending final publication"}

Key findings

Post-intervention, MBSR participants demonstrated decreased BOLD activation in the right ventrolateral prefrontal cortex (vlPFC)/lateral orbitofrontal cortex (OFC) and left medial temporal gyrus (MTG) in response to emotion-relative-to-neutral words compared to wait-list controls; this reduction in lateral prefrontal/orbitofrontal cortex reactivity was associated with increased self-reported mindfulness. Across all participants (i.e., not specific to group), decreased salience network reactivity at the post-intervention time point was associated with reduced psychological distress and reduced airway inflammation. Six-month follow-up findings were described in the abstract but were truncated in the provided text and are therefore not reportable here. Specific effect sizes, confidence intervals, and p-values for the fMRI group × time interactions are not reported in the available abstract. No adverse events were described. NNT/NNH cannot be calculated from available data.

Practice implications

This RCT provides mechanistic neuroimaging evidence that MBSR-related clinical benefits in adults with asthma are accompanied by measurable changes in emotion-processing brain circuitry, specifically reduced reactivity in the vlPFC/OFC and salience network. The vlPFC/OFC reduction was specific to the MBSR group relative to controls and correlated with increased mindfulness, suggesting a plausible dose-response neural pathway. The salience network finding was transdiagnostic across participants and linked to both psychological and inflammatory outcomes, offering preliminary support for a neuroimmune mechanism connecting emotional regulation to airway biology. However, this study does not establish causality between neural changes and clinical outcomes (correlation, not mediation, is demonstrated). The findings apply to meditation-naïve adults with asthma at a single academic center; generalizability to severe or biologic-treated asthma, pediatric populations, and diverse ethnic groups is uncertain. Critically, this manuscript was available only in unedited early-access form at the time of this summary, and final published statistics may differ. Practice should not change based on this study alone, but it strengthens the rationale for adjunctive use of MBSR in asthma management and for identifying neuroimmune phenotypes that may benefit most. __LIMITATIONS__ Modest sample size (n = 72 randomized; n = 67 at T2) limits statistical power for subgroup and secondary neuroimaging analyses and increases risk of false-positive findings in voxelwise comparisons.,Single academic center enrollment limits generalizability to community and non-academic settings.,Wait-list control does not control for non-specific effects of group participation, expectancy, or therapist contact (no active comparator such as a health education program).,Blinding: participants and instructors cannot be blinded to intervention assignment; fMRI analysis teams may have been blinded, but this is not stated in the abstract.,The abstract was truncated at the 6-month follow-up section; durability of neural changes and their clinical correlates beyond the post-intervention period cannot be assessed from available text.,fMRI outcome measures (BOLD signal changes) are mechanistic and neurobiological, not validated clinical endpoints; translation to patient-relevant outcomes (exacerbation rates, lung function, quality of life) requires further demonstration.,Exclusion of individuals with any prior meditation experience limits applicability to the growing population with some mindfulness exposure.,No formal primary endpoint pre-specified; multiple fMRI contrasts and voxelwise analyses increase the risk of Type I error despite whole-brain correction.,Funding source not disclosed in the abstract, preventing assessment of potential conflicts of interest.,Manuscript is an unedited early-access version; statistical values and conclusions may be revised at final publication. __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ This RCT provides the first task-based fMRI evidence that MBSR reduces reactivity in the vlPFC/OFC and salience network in adults with asthma, with these changes correlated with improvements in mindfulness, psychological distress, and airway inflammation. Findings are mechanistically informative and biologically plausible but are limited by sample size, a passive control, an absent formal primary endpoint, and availability only as an unedited preprint. MBSR may be considered a reasonable adjunct to standard asthma care for psychologically distressed patients, but practice should not change on the basis of these neuroimaging data alone pending replication and final publication.

Evidence appraisal

Evidence quality rating
5/10
Clinical applicability score
5/10